The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.46

Today's change-0.01 -0.68%
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.46

Today's change-0.01 -0.68%
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc down (U.S.)$0.01

Infinity Pharmaceuticals Inc closed lower Friday, dropping (U.S.)$0.01 or 0.68% to (U.S.)$1.46. Although unchanged over the last five days, shares are down 81.40% for the last year to date. This security has underperformed the S&P 500 by 96.00% during the last year.

Key company metrics

  • Open(U.S.) $1.46
  • Previous close(U.S.) $1.47
  • High(U.S.) $1.50
  • Low(U.S.) $1.45
  • Bid / Ask(U.S.) $1.40 / (U.S.) $2.67
  • YTD % change-81.40%
  • Volume176,216
  • Average volume (10-day)430,922
  • Average volume (1-month)396,319
  • Average volume (3-month)1,161,891
  • 52-week range(U.S.) $1.24 to (U.S.) $10.85
  • Beta1.88
  • Trailing P/E5.04×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.29
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue99991
Total other revenue--------
Total revenue99991
Gross profit--------
Total cost of revenue--------
Total operating expense-44504847
Selling / general / administrative1611910
Research & development53393938
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income53-41-3943
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax53-41-3943
Income after tax53-41-3943
Income tax, total----00
Net income53-41-3943
Total adjustments to net income-------1
Net income before extra. items53-41-3943
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items53-41-3942
Inc. avail. to common incl. extra. items53-41-3942
Diluted net income53-41-3942
Dilution adjustment0----0
Diluted weighted average shares49494950
Diluted EPS excluding extraordinary itemsvalue per share1.07-0.82-0.800.84
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share1.07-0.82-0.800.84